BRAF and primary cutaneous T-cell non-Hodgkin lymphoma: Chromosomal instability as well as dysregulated expression of many genes such as cancer testis and meiomitosis genes, Suppressor of cytokine signaling 3 (SOCS3), B-Raf proto-oncogene, serine/threonine kinase (BRAF), Interleukin-2 receptor common gamma chain, Thymocyte selection-associated high-mobility group box (TOX), among others [reviewed in (72, 73)] were reported in CTCL patients.